Creative Medical Technology Holdings Inc (CELZ)
4.43
-0.04
(-0.84%)
USD |
NASDAQ |
May 31, 16:00
4.44
+0.01
(+0.23%)
After-Hours: 20:00
Creative Medical Technology Holdings Enterprise Value: -3.035M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 31, 2024 | -3.035M |
May 30, 2024 | -2.984M |
May 29, 2024 | -3.143M |
May 28, 2024 | -3.076M |
May 24, 2024 | -3.197M |
May 23, 2024 | -3.076M |
May 22, 2024 | -3.069M |
May 21, 2024 | -3.076M |
May 20, 2024 | -3.210M |
May 17, 2024 | -3.008M |
May 16, 2024 | -3.156M |
May 15, 2024 | -3.076M |
May 14, 2024 | -3.022M |
May 13, 2024 | -3.170M |
May 10, 2024 | -3.143M |
May 09, 2024 | -3.174M |
May 08, 2024 | -2.998M |
May 07, 2024 | -2.767M |
May 06, 2024 | -2.957M |
May 03, 2024 | -3.045M |
May 02, 2024 | -2.835M |
May 01, 2024 | -2.801M |
April 30, 2024 | -2.984M |
April 29, 2024 | -3.059M |
April 26, 2024 | -3.147M |
Date | Value |
---|---|
April 25, 2024 | -3.038M |
April 24, 2024 | -2.482M |
April 23, 2024 | -2.468M |
April 22, 2024 | -2.455M |
April 19, 2024 | -2.482M |
April 18, 2024 | -2.482M |
April 17, 2024 | -2.231M |
April 16, 2024 | -1.953M |
April 15, 2024 | -1.940M |
April 12, 2024 | -1.950M |
April 11, 2024 | -1.604M |
April 10, 2024 | -1.428M |
April 09, 2024 | -1.368M |
April 08, 2024 | -1.516M |
April 05, 2024 | -1.53M |
April 04, 2024 | -1.522M |
April 03, 2024 | -1.557M |
April 02, 2024 | -1.394M |
April 01, 2024 | -1.476M |
March 28, 2024 | -2.919M |
March 27, 2024 | -3.001M |
March 26, 2024 | -3.082M |
March 25, 2024 | -2.634M |
March 22, 2024 | -2.946M |
March 21, 2024 | -2.721M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-17.11M
Minimum
Dec 22 2022
69.86M
Maximum
Feb 10 2021
4.119M
Average
1.581M
Median
Oct 29 2019
Enterprise Value Benchmarks
Avid Bioservices Inc | 623.63M |
Viking Therapeutics Inc | 5.907B |
Avinger Inc | 11.23M |
Aptevo Therapeutics Inc | -7.231M |
Absci Corp | 321.59M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -1.042M |
Total Expenses (Quarterly) | 1.123M |
EPS Diluted (Quarterly) | -0.73 |
Earnings Yield | -84.42% |
Normalized Earnings Yield | -84.88 |